131 related articles for article (PubMed ID: 23216929)
1. Radiation treatment with volumetric modulated arc therapy of hepatocellular carcinoma patients. Early clinical outcome and toxicity profile from a retrospective analysis of 138 patients.
Wang PM; Hsu WC; Chung NN; Chang FL; Fogliata A; Cozzi L
Radiat Oncol; 2012 Dec; 7():207. PubMed ID: 23216929
[TBL] [Abstract][Full Text] [Related]
2. Feasibility of stereotactic body radiation therapy with volumetric modulated arc therapy and high intensity photon beams for hepatocellular carcinoma patients.
Wang PM; Hsu WC; Chung NN; Chang FL; Jang CJ; Fogliata A; Scorsetti M; Cozzi L
Radiat Oncol; 2014 Jan; 9():18. PubMed ID: 24410988
[TBL] [Abstract][Full Text] [Related]
3. Radiotherapy with volumetric modulated arc therapy for hepatocellular carcinoma patients ineligible for surgery or ablative treatments.
Wang PM; Hsu WC; Chung NN; Chang FL; Fogliata A; Cozzi L
Strahlenther Onkol; 2013 Apr; 189(4):301-7. PubMed ID: 23420547
[TBL] [Abstract][Full Text] [Related]
4. Stereotactic body radiation therapy using a respiratory-gated volumetric-modulated arc therapy technique for small hepatocellular carcinoma.
Jeong Y; Jung J; Cho B; Kwak J; Jeong C; Kim JH; Park JH; Kim SY; Shim JH; Kim KM; Lim YS; Lee HC; Yoon SM
BMC Cancer; 2018 Apr; 18(1):416. PubMed ID: 29653562
[TBL] [Abstract][Full Text] [Related]
5. Helical IMRT-Based Stereotactic Body Radiation Therapy Using an Abdominal Compression Technique and Modified Fractionation Regimen for Small Hepatocellular Carcinoma.
Chen YX; Zhuang Y; Yang P; Fan J; Zhou J; Hu Y; Zhu WC; Sun J; Zeng ZC
Technol Cancer Res Treat; 2020; 19():1533033820937002. PubMed ID: 32613904
[TBL] [Abstract][Full Text] [Related]
6. High-dose radiotherapy with intensity-modulated radiation therapy for advanced hepatocellular carcinoma.
Kang MK; Kim MS; Kim SK; Ye GW; Lee HJ; Kim TN; Eun JR
Tumori; 2011; 97(6):724-31. PubMed ID: 22322838
[TBL] [Abstract][Full Text] [Related]
7. SBRT for Hepatocellular Carcinoma: 8-Year Experience from a Regional Transplant Center.
Qiu H; Moravan MJ; Milano MT; Usuki KY; Katz AW
J Gastrointest Cancer; 2018 Dec; 49(4):463-469. PubMed ID: 28710606
[TBL] [Abstract][Full Text] [Related]
8. Study of local three-dimensional conformal radiotherapy combined with transcatheter arterial chemoembolization for patients with stage III hepatocellular carcinoma.
Li B; Yu J; Wang L; Li C; Zhou T; Zhai L; Xing L
Am J Clin Oncol; 2003 Aug; 26(4):e92-9. PubMed ID: 12902905
[TBL] [Abstract][Full Text] [Related]
9. Treatment variables related to liver toxicity in patients with hepatocellular carcinoma, Child-Pugh class A and B enrolled in a phase 1-2 trial of stereotactic body radiation therapy.
Lasley FD; Mannina EM; Johnson CS; Perkins SM; Althouse S; Maluccio M; Kwo P; Cárdenes H
Pract Radiat Oncol; 2015; 5(5):e443-e449. PubMed ID: 25899219
[TBL] [Abstract][Full Text] [Related]
10. Phase I-II study of hypofractionated simultaneous integrated boost using volumetric modulated arc therapy for adjuvant radiation therapy in breast cancer patients: a report of feasibility and early toxicity results in the first 50 treatments.
Scorsetti M; Alongi F; Fogliata A; Pentimalli S; Navarria P; Lobefalo F; Garcia-Etienne C; Clivio A; Cozzi L; Mancosu P; Nicolini G; Vanetti E; Eboli M; Rossetti C; Rubino A; Sagona A; Arcangeli S; Gatzemeier W; Masci G; Torrisi R; Testori A; Alloisio M; Santoro A; Tinterri C
Radiat Oncol; 2012 Aug; 7():145. PubMed ID: 22929062
[TBL] [Abstract][Full Text] [Related]
11. RapidArc vs intensity-modulated radiation therapy for hepatocellular carcinoma: a comparative planning study.
Park JM; Kim K; Chie EK; Choi CH; Ye SJ; Ha SW
Br J Radiol; 2012 Jul; 85(1015):e323-9. PubMed ID: 22745211
[TBL] [Abstract][Full Text] [Related]
12. Superior liver sparing by combined coplanar/noncoplanar volumetric-modulated arc therapy for hepatocellular carcinoma: a planning and feasibility study.
Tsai YC; Tsai CL; Hsu FM; Jian-Kuen W; Chien-Jang W; Cheng JC
Med Dosim; 2013; 38(4):366-71. PubMed ID: 23769922
[TBL] [Abstract][Full Text] [Related]
13. Three-dimensional conformal radiation therapy for unresectable hepatocellular carcinoma patients who had failed with or were unsuited for transcatheter arterial chemoembolization.
Liu MT; Li SH; Chu TC; Hsieh CY; Wang AY; Chang TH; Pi CP; Huang CC; Lin JP
Jpn J Clin Oncol; 2004 Sep; 34(9):532-9. PubMed ID: 15466827
[TBL] [Abstract][Full Text] [Related]
14. The challenge of inoperable hepatocellular carcinoma (HCC): results of a single-institutional experience on stereotactic body radiation therapy (SBRT).
Scorsetti M; Comito T; Cozzi L; Clerici E; Tozzi A; Franzese C; Navarria P; Fogliata A; Tomatis S; D'Agostino G; Iftode C; Mancosu P; Ceriani R; Torzilli G
J Cancer Res Clin Oncol; 2015 Jul; 141(7):1301-9. PubMed ID: 25644863
[TBL] [Abstract][Full Text] [Related]
15. Dose escalation by intensity modulated radiotherapy in liver-directed concurrent chemoradiotherapy for locally advanced BCLC stage C hepatocellular carcinoma.
Byun HK; Kim HJ; Im YR; Kim DY; Han KH; Seong J
Radiother Oncol; 2019 Apr; 133():1-8. PubMed ID: 30935563
[TBL] [Abstract][Full Text] [Related]
16. Superselective yttrium-90 radioembolization for hepatocellular carcinoma yields high response rates with minimal toxicity.
Padia SA; Kwan SW; Roudsari B; Monsky WL; Coveler A; Harris WP
J Vasc Interv Radiol; 2014 Jul; 25(7):1067-73. PubMed ID: 24837982
[TBL] [Abstract][Full Text] [Related]
17. Tumor Targeting and Three-Dimensional Voxel-Based Dosimetry to Predict Tumor Response, Toxicity, and Survival after Yttrium-90 Resin Microsphere Radioembolization in Hepatocellular Carcinoma.
Allimant C; Kafrouni M; Delicque J; Ilonca D; Cassinotto C; Assenat E; Ursic-Bedoya J; Pageaux GP; Mariano-Goulart D; Aho S; Guiu B
J Vasc Interv Radiol; 2018 Dec; 29(12):1662-1670.e4. PubMed ID: 30217745
[TBL] [Abstract][Full Text] [Related]
18. Development and validation of a nomogram for radiation-induced hepatic toxicity after intensity modulated radiotherapy for hepatocellular carcinoma: a retrospective study.
Wu Q; Wang Y; Wei Y; Yang Z; Chen K; Li J; Li L; Su T; Liang S
Jpn J Clin Oncol; 2024 Jun; 54(6):699-707. PubMed ID: 38376811
[TBL] [Abstract][Full Text] [Related]
19. Feasibility and efficacy of stereotactic ablative radiotherapy for Barcelona Clinic Liver Cancer-C stage hepatocellular carcinoma.
Bae SH; Kim MS; Cho CK; Kim KB; Lee DH; Han CJ; Park SC; Kim YH
J Korean Med Sci; 2013 Feb; 28(2):213-9. PubMed ID: 23400333
[TBL] [Abstract][Full Text] [Related]
20. Proton-beam therapy for hepatocellular carcinoma associated with portal vein tumor thrombosis.
Sugahara S; Nakayama H; Fukuda K; Mizumoto M; Tokita M; Abei M; Shoda J; Matsuzaki Y; Thono E; Tsuboi K; Tokuuye K
Strahlenther Onkol; 2009 Dec; 185(12):782-8. PubMed ID: 20013087
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
